PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Hookah pipes, smokeless tobacco snus associated with smoking onset

2014-12-08
(Press-News.org) Smoking water pipe tobacco from hookahs and using the smokeless tobacco snus were associated with initiating cigarette smoking and smoking cigarettes in the past 30 days among previously nonsmoking teenagers and young adults, according to a study published online by JAMA Pediatrics.

The Food and Drug Administration regulates cigarettes, loose tobacco and smokeless tobacco products. However, the FDA does not regulate the manufacturing, distribution and marketing of other tobacco products, such as water pipe tobacco, and many of those products are used by teenagers and young adults because of their appealing flavors, according to background information in the study.

Samir Soneji, Ph.D., of the Geisel School of Medicine at Dartmouth College, Lebanon, N.H., and co-authors examined whether the use of two alternative tobacco products - water pipe tobacco and snus - by noncigarette smoking teenagers and young people increased their risk of subsequently picking up the cigarette habit.

The authors conducted a study between October 2010 and June 2011 of 2,541 people between the ages of 15 and 23 to determine whether they had smoked cigarettes, smoked water pipe tobacco or used snus. At follow-up two years later (between October 2012 and March 2013) the authors assessed whether noncigarette smokers at the start of the study had subsequently tried cigarette smoking, were current smokers (smoked cigarettes in the past 30 days) or were high-intensity cigarette smokers.

The results show that of the 2,541 individuals at the study baseline, 38.7 percent had tried cigarettes, 15 percent were current smokers, 20.1 percent had smoked water pipe tobacco and 9.4 percent used snus. Of the 1,596 individuals who completed surveys at both the start of the study and at the two year follow-up, 1,048 (65.7 percent) had never smoked cigarettes at the study baseline and, of those 1,048 people, 71 (6.8 percent) had smoked water pipe tobacco and 20 (1.9 percent) had used snus at baseline.

According to the results, 39 percent of the baseline noncigarette smokers who had also smoked water pipe tobacco at baseline had started smoking cigarettes at follow-up compared with 19.9 percent of those individuals who had not smoked water pipe tobacco; 11 percent of the baseline noncigarette smokers who had also smoked water pipe tobacco were current cigarette smokers (smoked cigarettes in the past 30 days) at the follow-up compared with 4.9 percent of those who had not smoked water pipe tobacco; 55 percent of the baseline noncigarette smokers who had also used snus at baseline had started smoking at follow-up compared with 20.5 percent of those who had not used snus; and 25 percent of the baseline noncigarette smokers who also used snus at baseline were current cigarette smokers at follow-up compared with 5 percent of those who had not used snus.

The odds of initiating cigarette smoking, being a current smoker at follow-up or having a higher intensity of smoking (which was rated according to how many days and how many cigarettes someone smoked) were higher for individuals who had smoked water pipe tobacco or used snus at the study baseline than those individuals who had not, the results also show.

"In conclusion, our study demonstrates that WTS [water pipe tobacco smoking] and snus use among noncigarette smoking adolescents and young adults were longitudinally associated with subsequent cigarette smoking. Yet, water pipe tobacco remains largely unregulated by the FDA, and snus is less regulated than other smokeless tobacco. Even if regulation proposed in 2013 becomes final, U.S. tobacco companies may legally contest the new rule, which could delay its implementation. The success of FDA tobacco regulatory control policies will depend, in part, on their ability to reduce the use of alternative tobacco products that may lead to subsequent cigarette smoking," the study concludes.

INFORMATION:

(JAMA Pediatr. Published online December 8, 2014. doi:10.1001/jamapediatrics.2014.2697. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor's Note: Authors made funding/support disclosures. Please see article for additional information, including other authors, author contributions and affiliations, etc.

Media Advisory: To contact study author Samir Soneji, Ph.D., call Annmarie Christensen 603-653-0897 or email Annmarie.Christensen@dartmouth.edu.



ELSE PRESS RELEASES FROM THIS DATE:

Impossible? Can researchers develop 100 drugs in 10 years?

2014-12-08
Salt Lake City - Develop 100 drugs in 10 years. That's the ambitious goal set by a group of scientists and engineers at the University of Utah, founders of Recursion Pharmaceuticals, a start-up company that is able to quickly and affordably identify unexpected ways a drug could be used by testing it on diseased cells. The disruptive approach to drug development, aided by custom-designed software capable of tracking changes, or signs of healing, in cells, could speed discovery of therapies for so-called "orphan" diseases. Scientists at Recursion have already identified ...

Preeclampsia during mother's pregnancy associated with greater autism risk

2014-12-08
(SACRAMENTO, Calif.) -- Children with autism spectrum disorder (ASD) were more than twice as likely to have been exposed in utero to preeclampsia, and the likelihood of an autism diagnosis was even greater if the mother experienced more severe disease, a large study by researchers with the UC Davis MIND Institute has found. Women with preeclampsia experience hypertension during the latter half of their pregnancies, and may have increased levels of protein in their urine and edema, or fluid retention. Preeclampsia can develop into eclampsia, a life-threatening condition ...

Asbestos: An ongoing challenge to global health

Asbestos: An ongoing challenge to global health
2014-12-08
New York, NY, December 8, 2014 - Challenges to global health can evolve from policies and decisions that take years or decades to unfold. An article in the current issue of the Annals of Global Health describes the current state of asbestos use worldwide, a story that began over 100 years ago, and the real and contrived controversies regarding asbestos. At the peak of asbestos use in 1972 in the United States, more than 775,000 tons of asbestos were used, much of it by the construction trades and shipbuilding industry, in addition to the manufacturing of many consumer ...

Each dollar spent on kids' nutrition can yield more than $100 later

2014-12-08
There are strong economic incentives for governments to invest in early childhood nutrition, reports a new paper from the University of Waterloo and Cornell University. Published for the Copenhagen Consensus Centre, the paper reveals that every dollar spent on nutrition during the first 1,000 days of a child's life can provide a country up to $166 in future earnings. "The returns on investments in nutrition have high benefit-cost ratios, especially in countries with higher income levels and a growing economy," said Professor Susan Horton, of the School of Public Health ...

Low-crime, walkable neighborhoods promote mental health in older Latinos

2014-12-08
Older Latinos living in the U.S. who perceive their neighborhoods as safer and more walkable are less likely to develop severe depressive symptoms, and the effect may be long term, a new study suggests. Researchers examined links between the onset of depressive symptoms in 570 older Latino adults and various characteristics of the Greater Los Angeles neighborhoods they lived in, including crime, the availability and quality of sidewalks, traffic safety and aesthetics. Participants ranged in age from 60 to 90, and 351 of them screened positive for low levels of depression ...

Tramadol associated with increased risk of hospitalization for hypoglycemia

2014-12-08
The opioid pain-reliever tramadol appears to be associated with an increased risk of hospitalization for hypoglycemia, a potentially fatal condition caused by low blood sugar, according to a report published online by JAMA Internal Medicine. Tramadol hydrochloride is a weak opioid whose use has increased steadily worldwide. However, concerns have been raised about the drug and an increased risk for hypoglycemia. Because of increasing use of the doctor-prescribed pain reliever, researchers at McGill University and the Lady Davis Institute at the Jewish General Hospital ...

Vaccine holds hope of preventing antibiotic resistant skin infections

Vaccine holds hope of preventing antibiotic resistant skin infections
2014-12-08
LOS ANGELES - (Dec. 8, 2014) - In the U.S. and around the globe, skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus (MRSA) continue to endanger the health and lives of patients and otherwise healthy individuals. Treatment is difficult because MRSA is resistant to many antibiotics, and the infections can recur, placing family members and other close contacts at risk of infection. A study reported online today in the Proceedings of the National Academy of Sciences USA holds new hope for preventing or reducing the severity of infections ...

Shedding new light on the formation of emotional fear memories

2014-12-08
Everyday events are easy to forget, but unpleasant ones can remain engraved in the brain. A new study published in the Proceedings of the National Academy of Sciences identifies a neural mechanism through which unpleasant experiences are translated into signals that trigger fear memories by changing neural connections in a part of the brain called the amygdala. The findings show that a long-standing theory on how the brain forms memories, called Hebbian plasticity, is partially correct, but not as simple as was originally proposed. The effort led by Joshua Johansen from ...

New therapy holds promise for restoring vision

New therapy holds promise for restoring vision
2014-12-08
A new genetic therapy not only helped blind mice regain enough light sensitivity to distinguish flashing from non-flashing lights, but also restored light response to the retinas of dogs, setting the stage for future clinical trials of the therapy in humans. The therapy employs a virus to insert a gene for a common ion channel into normally blind cells of the retina that survive after the light-responsive rod and cone photoreceptor cells die as a result of diseases such as retinitis pigmentosa. Photoswitches - chemicals that change shape when hit with light -are then ...

Heat-shock protein enables tumor evolution and drug resistance in breast cancer

2014-12-08
CAMBRIDGE, Mass. (December 8, 2014) - Long known for its ability to help organisms successfully adapt to environmentally stressful conditions, the highly conserved molecular chaperone heat-shock protein 90 (HSP90) also enables estrogen receptor-positive (ER+) breast cancers to develop resistance to hormonal therapy. This HSP90-mediated evolutionary mechanism of drug resistance, reported by Whitehead Institute scientists in this week's online edition of the Proceedings of the National Academy of Sciences (PNAS), provides a strong therapeutic rationale for combining HSP90 ...

LAST 30 PRESS RELEASES:

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments

Using smartphones to improve disaster search and rescue

Robust new photocatalyst paves the way for cleaner hydrogen peroxide production and greener chemical manufacturing

Ultrafast material captures toxic PFAS at record speed and capacity

Plant phenolic acids supercharge old antibiotics against multidrug resistant E. coli

UNC-Chapel Hill study shows AI can dramatically speed up digitizing natural history collections

OYE Therapeutics closes $5M convertible note round, advancing toward clinical development

Membrane ‘neighborhood’ helps transporter protein regulate cell signaling

Naval aviator turned NPS doctoral student earns national recognition for applied quantum research

[Press-News.org] Hookah pipes, smokeless tobacco snus associated with smoking onset